Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,425-2,436 of 10,612
Behavioral study icon
CompletedNCT01422239

A Smoking Cessation Treatment for Adult Women

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Other study type icon
TerminatedNCT05109195

A Standard of Care Study of people with Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

This study was terminated in the United States and in the United Kingdom. It focuses on depression.

In United States
DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 74 Years
Countries
United States, United Kingdom
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT01940159

Safety study of SEP-363856 in schizophrenia

This study is completed in the United States. It is testing SEP-363856 for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00634348

Ziprasidone and Aripiprazole for schizophrenia

This study is completed in the United States. It is testing ziprasidone and Aripiprazole for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.